Ep. 155 Managing Biochemical Recurrence After Prostatectomy with Dr. James Eastham episode artwork

EPISODE · Mar 5, 2024 · 56 MIN

Ep. 155 Managing Biochemical Recurrence After Prostatectomy with Dr. James Eastham

from BackTable Urology · host BackTable

In this episode of BackTable Urology, Dr. James Eastham, chief of urology at Memorial Sloan Kettering Cancer Center, discusses evolving approaches and treatments in prostate cancer. First, he discusses topics such as patient preparation, pre-treatment discussions, and individualized treatment options based on the patient's risk levels. Dr. Eastham also summarizes crucial advancements in testing and imaging prostate cancers, including the use of genetic and biochemical markers, like PSA levels. Additionally, he emphasizes how advances in radiation therapy have improved treatment outcomes and patient experiences. Finally, Dr. Eastham emphasizes the need for consistent monitoring and communication with patients during and post-treatment. --- CHECK OUT OUR SPONSOR Veracyte https://www.veracyte.com/decipher --- SHOW NOTES 00:00 - Introduction 06:24 - Treatment Strategies and Patient Preferences 11:30 - Exploring the Role of Imaging in Prostate Cancer Treatment 18:29 - Dealing with Persistently Detectable PSA and Pre-op Staging 27:48 - Understanding Prostate Cancer Recurrence 36:08 - The Role of PSA Doubling Time in Treatment Decisions 43:34 - The Future of Personalized Medicine and Genomic Classifiers in Prostate Cancer 52:42 - The Importance of Patient Education and Preparation --- RESOURCES Decipher Prostate by Veracyte: https://www.veracyte.com/decipher-prostate/

In this episode of BackTable Urology, Dr. James Eastham, chief of urology at Memorial Sloan Kettering Cancer Center, discusses evolving approaches and treatments in prostate cancer. First, he discusses topics such as patient preparation, pre-treatment discussions, and individualized treatment options based on the patient's risk levels. Dr. Eastham also summarizes crucial advancements in testing and imaging prostate cancers, including the use of genetic and biochemical markers, like PSA levels. Additionally, he emphasizes how advances in radiation therapy have improved treatment outcomes and patient experiences. Finally, Dr. Eastham emphasizes the need for consistent monitoring and communication with patients during and post-treatment. --- CHECK OUT OUR SPONSOR Veracyte https://www.veracyte.com/decipher --- SHOW NOTES 00:00 - Introduction 06:24 - Treatment Strategies and Patient Preferences 11:30 - Exploring the Role of Imaging in Prostate Cancer Treatment 18:29 - Dealing with Persistently Detectable PSA and Pre-op Staging 27:48 - Understanding Prostate Cancer Recurrence 36:08 - The Role of PSA Doubling Time in Treatment Decisions 43:34 - The Future of Personalized Medicine and Genomic Classifiers in Prostate Cancer 52:42 - The Importance of Patient Education and Preparation --- RESOURCES Decipher Prostate by Veracyte: https://www.veracyte.com/decipher-prostate/

NOW PLAYING

Ep. 155 Managing Biochemical Recurrence After Prostatectomy with Dr. James Eastham

0:00 56:52

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of BackTable Urology?

This episode is 56 minutes long.

When was this BackTable Urology episode published?

This episode was published on March 5, 2024.

What is this episode about?

In this episode of BackTable Urology, Dr. James Eastham, chief of urology at Memorial Sloan Kettering Cancer Center, discusses evolving approaches and treatments in prostate cancer. First, he discusses topics such as patient preparation,...

Can I download this BackTable Urology episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!